title: Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions.
abstract: Integration of HIV-1 cDNA into the host genome is a crucial step for viral propagation. Two nucleotides, cytosine and adenine (CA), conserved at the 3' end of the viral cDNA genome, are cleaved by the viral integrase (IN) enzyme. As IN plays a crucial role in the early stages of the HIV-1 life cycle, substrate blockage of IN is an attractive strategy for therapeutic interference. In this study, we used the 2-LTR-circle junctions of HIV-1 DNA as a model to design zinc finger protein (ZFP) targeting at the end terminal portion of HIV-1 LTR. A six-contiguous ZFP, namely 2LTRZFP was designed using zinc finger tools. The designed motif was expressed and purified from E. coli to determine its binding properties. Surface plasmon resonance (SPR) was used to determine the binding affinity of 2LTRZFP to its target DNA. The level of dissociation constant (K(d)) was 12.0 nM. The competitive SPR confirmed that 2LTRZFP specifically interacted with its target DNA. The qualitative binding activity was subsequently determined by EMSA and demonstrated the aforementioned correlation. In addition, molecular modeling and binding energy analyses were carried out to provide structural insight into the binding of 2LTRZFP to the specific and nonspecific DNA target. It is suggested that hydrogen-bonding interactions play a key role in the DNA recognition mechanisms of the designed ZFP. Our study suggested an alternative HIV therapeutic strategy using ZFP interference of the HIV integration process.
authors.affiliation: Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
authors.forename: Supachai
authors.initials: S
authors.lastname: Sakkhachornphop
authors.forename: Supat
authors.initials: S
authors.lastname: Jiranusornkul
authors.forename: Kanchanok
authors.initials: K
authors.lastname: Kodchakorn
authors.forename: Sawitree
authors.initials: S
authors.lastname: Nangola
authors.forename: Thira
authors.initials: T
authors.lastname: Sirisanthana
authors.forename: Chatchai
authors.initials: C
authors.lastname: Tayapiwatana
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D003001:Cloning, Molecular; D004247:DNA / Q000737:chemistry / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay; D019427:HIV Integrase / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D006367:HeLa Cells; D006801:Humans; D007700:Kinetics; D008954:Models, Biological; D008958:Models, Molecular; D008969:Molecular Sequence Data; D011485:Protein Binding / Q000235:genetics; D020349:Surface Plasmon Resonance; D013816:Thermodynamics; D016335:Zinc Fingers / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; D004247:DNA; D019427:HIV Integrase
references.citation: Proteins. 1995 Sep;23(1):12-31
references.pmid: 8539245
references.citation: Biochemistry. 2003 Aug 5;42(30):9235-47
references.pmid: 12885259
references.citation: Nat Med. 2002 Dec;8(12):1427-32
references.pmid: 12415262
references.citation: Expert Opin Investig Drugs. 2008 Mar;17(3):413-22
references.pmid: 18321239
references.citation: J Biol Chem. 2001 Aug 3;276(31):29466-78
references.pmid: 11340073
references.citation: J Virol. 1990 Oct;64(10):4903-6
references.pmid: 1697909
references.citation: Trends Genet. 1993 Dec;9(12):433-8
references.pmid: 8122311
references.citation: J Virol. 1991 Oct;65(10):5624-30
references.pmid: 1895409
references.citation: J Virol. 1995 May;69(5):3233-6
references.pmid: 7707558
references.citation: J Virol. 1996 Dec;70(12):9069-73
references.pmid: 8971046
references.citation: J Biol Chem. 2005 Oct 21;280(42):35588-97
references.pmid: 16107335
references.citation: Cell. 1979 Feb;16(2):323-32
references.pmid: 455438
references.citation: Mol Pharmacol. 2004 Jan;65(1):85-98
references.pmid: 14722240
references.citation: Mol Pharmacol. 2004 Dec;66(6):1361-71
references.pmid: 15340042
references.citation: J Biol Chem. 2004 Apr 9;279(15):14509-19
references.pmid: 14734553
references.citation: Proc Natl Acad Sci U S A. 1975 Feb;72(2):447-51
references.pmid: 1054828
references.citation: Proc Natl Acad Sci U S A. 1981 Jan;78(1):124-8
references.pmid: 6264426
references.citation: Sci Am. 1988 Oct;259(4):82-9
references.pmid: 3072675
references.citation: J Virol. 1993 Mar;67(3):1169-74
references.pmid: 8437208
references.citation: J Mol Biol. 2000 Nov 3;303(4):489-502
references.pmid: 11054286
references.citation: Science. 1989 Aug 11;245(4918):635-7
references.pmid: 2503871
references.citation: J Virol. 1995 May;69(5):3216-9
references.pmid: 7707554
references.citation: J R Soc Interface. 2008 Dec 6;5 Suppl 3:S191-8
references.pmid: 18782724
references.citation: Nucleic Acids Res. 2009 Mar;37(4):1193-201
references.pmid: 19129221
references.citation: Science. 1991 May 10;252(5007):809-17
references.pmid: 2028256
references.citation: J Mol Biol. 2005 Apr 22;348(1):85-100
references.pmid: 15808855
references.citation: Proc Natl Acad Sci U S A. 1980 Jul;77(7):3932-6
references.pmid: 6449003
references.citation: J Mol Biol. 1976 Sep 15;106(2):337-57
references.pmid: 185393
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1615-20
references.pmid: 12574502
references.citation: Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W516-23
references.pmid: 16845061
references.citation: EMBO J. 1985 Jun;4(6):1609-14
references.pmid: 4040853
references.citation: J HIV Ther. 2008 Jun;13(2):36-9
references.pmid: 18953272
references.citation: Structure. 1996 Oct 15;4(10):1171-80
references.pmid: 8939742
references.citation: HIV Med. 2008 Oct;9(9):765-70
references.pmid: 18651855
references.citation: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W526-31
references.pmid: 15980527
references.citation: J Virol. 1995 May;69(5):2729-36
references.pmid: 7535863
references.citation: J Virol. 2008 Aug;82(16):8013-21
references.pmid: 18524822
references.citation: Annu Rev Biochem. 1994;63:133-73
references.pmid: 7526778
references.citation: Methods Mol Biol. 1999;112:531-52
references.pmid: 10027275
references.citation: J Virol. 1977 Jan;21(1):119-30
references.pmid: 556779
references.citation: J Mol Biol. 2006 Oct 20;363(2):405-21
references.pmid: 16963084
references.citation: Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
references.pmid: 9254694
references.citation: J Virol. 1994 Dec;68(12):7825-32
references.pmid: 7966572
references.citation: J Virol. 1978 Jan;25(1):104-4
references.pmid: 202729
references.citation: J Virol. 1991 Sep;65(9):4636-44
references.pmid: 1870194
references.citation: Curr Med Chem. 2001 Nov;8(13):1543-72
references.pmid: 11562282
references.citation: J Drug Target. 2007 Jan;15(1):21-36
references.pmid: 17365271
references.citation: J Virol. 1997 Feb;71(2):1025-35
references.pmid: 8995622
references.citation: J Comput Chem. 2003 Dec;24(16):1999-2012
references.pmid: 14531054